Gri bio to present at alliance global partner's 2024 healthcare company showcase

Live webcast fireside chat on tuesday, may 21 st at 2:40 pm et la jolla, ca, may 14, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (nkt) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that marc hertz, phd, chief executive officer of gri bio, will participate in a fireside chat at the healthcare company showcase hosted by alliance global partners on may 21, 2024 at 2:40 pm et. a live webcast of the event will be available on the events page of the investors section of the company's website ( www.gribio.com ).
GRI Ratings Summary
GRI Quant Ranking